SIRNA LIMITED

Active Stratford-Upon-Avon

Other professional, scientific and technical activities n.e.c.

0 employees website.com
Other professional, scientific and technical activities n.e.c.
S

SIRNA LIMITED

Other professional, scientific and technical activities n.e.c.

Founded 17 Mar 2016 Active Stratford-Upon-Avon, England 0 employees website.com
Other professional, scientific and technical activities n.e.c.

Previous Company Names

REGENETY LIMITED 17 Mar 2016 — 10 May 2018
Accounts Submitted 25 May 2026 Next due 30 Apr 2026 2 months overdue
Confirmation Submitted 19 Mar 2026 Next due 29 Mar 2027 9 months remaining
Net assets £-39K £0 2024 year on year
Total assets £743K £0 2024 year on year
Total Liabilities £781K £0 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Celixir House Stratford-Upon-Avon Business & Technology Park Innovation Way Stratford-Upon-Avon CV37 7GZ England

Full company profile for SIRNA LIMITED (10069155), an active company based in Stratford-Upon-Avon, England. Incorporated 17 Mar 2016. Other professional, scientific and technical activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Aug → 31 Jul 2024
Type micro-entity
Next accounts 31 Jul 2025
Due by 30 Apr 2026 2 months overdue

Net Assets, Total Assets & Total Liabilities (2017–2024)

Cash in Bank

N/A

Net Assets

-£38.57k

Total Liabilities

£781.16k

Turnover

N/A

Employees

N/A

Debt Ratio

105%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Jul Year End
2023
31 Jul Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Reginald, Ajan TrevorDirectorBritishUnited Kingdom5417 Mar 2016Active

Shareholders

Shareholders (1)

Cell Therapy Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Cardiogeni Plc

United Kingdom

Active
Notified 6 Jan 2025
Nature of Control
  • Significant Influence Or Control,significant Influence Or Control As Firm

Cell Therapy Limited

Ceased 6 Jan 2025

Ceased

Group Structure

Group Structure

CARDIOGENI PLC united kingdom
SIRNA LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
25 May 2026AccountsAnnual accounts made up to 31 Jul 2025
19 Mar 2026Confirmation StatementConfirmation statement made on 15 Mar 2026 with no updates
28 May 2025AccountsAnnual accounts made up to 31 Jul 2024
21 May 2025Confirmation StatementConfirmation statement made on 15 Mar 2025 with no updates
10 Jan 2025OfficersTermination of Celixir Plc as director on 6 Jan 2025
25 May 2026 Accounts

Annual accounts made up to 31 Jul 2025

19 Mar 2026 Confirmation Statement

Confirmation statement made on 15 Mar 2026 with no updates

28 May 2025 Accounts

Annual accounts made up to 31 Jul 2024

21 May 2025 Confirmation Statement

Confirmation statement made on 15 Mar 2025 with no updates

10 Jan 2025 Officers

Termination of Celixir Plc as director on 6 Jan 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Jul 2025

1 weeks ago on 25 May 2026

Confirmation statement made on 15 Mar 2026 with no updates

2 months ago on 19 Mar 2026

Annual accounts made up to 31 Jul 2024

1 years ago on 28 May 2025

Confirmation statement made on 15 Mar 2025 with no updates

1 years ago on 21 May 2025

Termination of Celixir Plc as director on 6 Jan 2025

1 years ago on 10 Jan 2025